{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:28:12Z","timestamp":1788827292239,"version":"build-2803163510"},"reference-count":143,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004442","name":"Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch Poland","doi-asserted-by":"publisher","award":["2016\/21\/D\/NZ5\/01913"],"award-info":[{"award-number":["2016\/21\/D\/NZ5\/01913"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>We studied the associations between 3\u2032UTR genetic variants in ADME genes, clinical factors, and the risk of breast cancer chemotherapy toxicity. Those variants and factors were tested in relation to seven symptoms belonging to myelotoxicity (anemia, leukopenia, neutropenia), gastrointestinal side effects (vomiting, nausea), nephrotoxicity, and hepatotoxicity, occurring in overall, early, or recurrent settings. The cumulative risk of overall symptoms of anemia was connected with AKR1C3 rs3209896 AG, ERCC1 rs3212986 GT, and &gt;6 cycles of chemotherapy; leukopenia was determined by ABCC1 rs129081 allele G and DPYD rs291593 allele T; neutropenia risk was correlated with accumulation of genetic variants of DPYD rs291583 allele G, ABCB1 rs17064 AT, and positive HER2 status. Risk of nephrotoxicity was determined by homozygote DPYD rs291593, homozygote AKR1C3 rs3209896, postmenopausal age, and negative ER status. Increased risk of hepatotoxicity was connected with NR1\/2 rs3732359 allele G, postmenopausal age, and with present metastases. The risk of nausea and vomiting was linked to several genetic factors and premenopausal age. We concluded that chemotherapy tolerance emerges from the simultaneous interaction of many genetic and clinical factors.<\/jats:p>","DOI":"10.3390\/ijms252212283","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:07:09Z","timestamp":1731902829000},"page":"12283","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Are the Common Genetic 3\u2032UTR Variants in ADME Genes Playing a Role in Tolerance of Breast Cancer Chemotherapy?"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-6531","authenticated-orcid":false,"given":"Karolina","family":"T\u0119cza","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7392-922X","authenticated-orcid":false,"given":"Magdalena","family":"Kalinowska-Herok","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4115-3751","authenticated-orcid":false,"given":"Dagmara","family":"Rusinek","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-7118","authenticated-orcid":false,"given":"Artur","family":"Zajkowicz","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0189-9711","authenticated-orcid":false,"given":"Aleksandra","family":"Pfeifer","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8989-0075","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Oczko-Wojciechowska","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6289-2329","authenticated-orcid":false,"given":"Jolanta","family":"Pamu\u0142a-Pi\u0142at","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Genetics, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0897190014546108","article-title":"Antineoplastic agents and the associated myelosuppressive effects: A review","volume":"27","author":"Barreto","year":"2014","journal-title":"J. Pharm. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/psp4.12459","article-title":"Quantifying drug-induced bone marrow toxicity using a novel haematopoiesis systems pharmacology model","volume":"11","author":"Fornari","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_3","first-page":"CD002225","article-title":"Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix","volume":"20","author":"Green","year":"2005","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Grigiene, R., Valuckas, K.P., Aleknavicius, E., Kurtinaitis, J., and Letautiene, S.R. (2007). The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone. BMC Cancer, 7.","DOI":"10.1186\/1471-2407-7-234"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5301\/ijbm.5000279","article-title":"Relationship between clinical toxicities and ERCC1 rs3212986 and XRCC3 rs861539 polymorphisms in cervical cancer patients","volume":"33","author":"Soares","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.critrevonc.2013.12.006","article-title":"Risk factors for febrile neutropenia amonpatients with cancer receiving chemotherapy: A systematic review","volume":"90","author":"Lyman","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Ahmed, J.H., Makonnen, E., Yimer, G., Seifu, D., Bekele, A., Assefa, M., Aseffa, A., Howe, R., Fotoohi, A., and Hassan, M. (2019). CYP2J2(\u2217)7 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00481"},{"key":"ref_8","first-page":"22","article-title":"Risk assessment and guidelines for first-cycle colony-stimulating factor use in the management of chemotherapy-induced neutropenia","volume":"20","author":"Crawford","year":"2006","journal-title":"Oncology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","article-title":"The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting","volume":"28","author":"Dranitsaris","year":"2017","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.jpainsymman.2013.06.012","article-title":"Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: Results from a European prospective observational study","volume":"47","author":"Molassiotis","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"ref_11","first-page":"2","article-title":"Chemotherapy-Induced Nausea and Vomiting","volume":"43","author":"Tilleman","year":"2018","journal-title":"US Pharm."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mosa, A., Hossain, A.M., Lavoie, B.J., and Yoo, I. (2020). Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00329"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function- measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/japtr.JAPTR_336_18","article-title":"Nephrotoxicity: Role and significance of renal biomarkers in the early detection of acute renal injury","volume":"10","author":"Rasheed","year":"2019","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200510-1666ST","article-title":"An Official ATS Statement: Hepatotoxicity of antituberculosis therapy","volume":"174","author":"Saukkonen","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/pr.109.001727","article-title":"Inflammatory stress and idiosyncratic hepatotoxicity: Hints from animal models","volume":"61","author":"Deng","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1365-2036.2007.03307.x","article-title":"Review article: Drug hepatotoxicity","volume":"25","author":"Chang","year":"2007","journal-title":"Aliment Pharmacol. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s10620-006-9472-y","article-title":"Drug-induced liver injury: Review article","volume":"52","author":"Bleibel","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Faraji, A., Dehghan Manshadi, H.R., Mobaraki, M., Zare, M., and Houshmand, M. (2016). Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168519"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ludovini, V., Antognelli, C., Rulli, A., Foglietta, J., Pistola, L., Eliana, R., Floriani, I., Nocentini, G., Tofanetti, F.R., and Piattoni, S. (2017). Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3483-2"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1389200218666171101124931","article-title":"Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia","volume":"19","author":"Herrero","year":"2018","journal-title":"Curr. Drug Metab."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"25355","DOI":"10.18632\/oncotarget.25256","article-title":"SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand","volume":"9","author":"Palmirotta","year":"2018","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Wei, R., Yang, F., Urban, T.J., Li, L., Chalasani, N., Flockhart, D.A., and Liu, W. (2012). Impact of the Interaction between 3\u2032-UTR SNPs and microRNA on the Expression of Human Xenobiotic Metabolism Enzyme and Transporter Genes. Front. Genet., 3.","DOI":"10.3389\/fgene.2012.00248"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s10552-013-0237-6","article-title":"Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: A case-controls study of contralateral breast cancer risk in the WECARE Study","volume":"8","author":"Brooks","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00280-019-03932-0","article-title":"Polymorphisms of genes encoding drug transporters or cytochrome P450 enzymes and association with clinical response in cancer patients: A systematic review","volume":"84","author":"Kulma","year":"2019","journal-title":"Cancer Chemother Pharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF00210743","article-title":"The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences","volume":"90","author":"Krawczak","year":"1992","journal-title":"Hum. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Li, G., Pan, T., Guo, D., and Li, L.C. (2014). Regulatory Variants and Disease: The E-Cadherin-160C\/A SNP as an Example. Mol. Biol. Int., 2014.","DOI":"10.1155\/2014\/967565"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13072-015-0050-4","article-title":"Making sense of GWAS: Using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome","volume":"30","author":"Tak","year":"2015","journal-title":"Epigenet. Chromatin"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Moszy\u0144ska, A., Gebert, M., Collawn, J.F., and Bartoszewski, R. (2017). SNPs in microRNA target sites and their potential role in human disease. Open Biol., 7.","DOI":"10.1098\/rsob.170019"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pamu\u0142a-Pi\u0142at, J., T\u0119cza, K., Kalinowska-Herok, M., and Grzybowska, E. (2020). Genetic 3\u2032UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-62662-z"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1158\/0008-5472.CAN-04-1608","article-title":"Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signalling","volume":"64","author":"Ji","year":"2004","journal-title":"Cancer Res."},{"key":"ref_33","first-page":"505","article-title":"The aldo-keto reductase AKR1C3 is a novel suppressor of cell differentiation that provides a plausible target for the non-cyclooxygenase-dependent antineoplastic actions of nonsteroidal anti-inflammatory drugs","volume":"63","author":"Desmond","year":"2003","journal-title":"Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Schulze, J.J., Karypidis, H., and Ekstr\u00f6m, L. (2012). Basal and Regulatory Promoter Studies of the AKR1C3 Gene in Relation to Prostate Cancer. Front. Pharmacol., 3.","DOI":"10.3389\/fphar.2012.00151"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/carcin\/bgn071","article-title":"Maternal and offspring genetic variants of AKR1C3 and the risk of childhood leukemia","volume":"29","author":"Liu","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/carcin\/bgn163","article-title":"Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes","volume":"29","author":"Figueroa","year":"2008","journal-title":"Carcinogenesis"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/aje\/kwp298","article-title":"Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk","volume":"170","author":"Reding","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/bcp.12021","article-title":"Correlation of aldo-ketoreductase (AKR)1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients","volume":"75","author":"Voon","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.12659\/MSM.912373","article-title":"Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis","volume":"20","author":"Wang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/15384047.2017.1295175","article-title":"Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer","volume":"18","author":"Tian","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2217\/pgs-2016-0093","article-title":"Polymorphisms of ABAT, SCN2A and ALDH5A1 may affect valproic acid responses in the treatment of epilepsy in Chinese","volume":"17","author":"Li","year":"2016","journal-title":"Pharmacogenomics"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1152\/physrev.00058.2017","article-title":"The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms","volume":"99","author":"Meech","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_43","first-page":"2702","article-title":"Polymorphisms in UGT2B4 and susceptibility to pancreatic cancer","volume":"8","author":"Che","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Medhasi, S., Pinthong, D., Pasomsub, E., Vanwong, N., Ngamsamut, N., Puangpetch, A., Chamnanphon, M., Hongkaew, Y., Pratoomwun, J., and Limsila, P. (2016). Pharmacogenomic Study Reveals New Variants of Drug Metabolizing Enzyme and Transporter Genes Associated with Steady-State Plasma Concentrations of Risperidone and 9-Hydroxyrisperidone in Thai Autism Spectrum Disorder Patients. Front. Pharmacol., 7.","DOI":"10.3389\/fphar.2016.00475"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/gcc.22167","article-title":"Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: Colon cancer family registry","volume":"53","author":"Scherer","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Vidal, A.C., Tucker, C., Schildkraut, J.M., Richardson, R.M., McPhail, M., Freedland, S.J., Hoyo, C., and Grant, D.J. (2013). Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study. BMC Cancer, 22.","DOI":"10.1186\/1471-2407-13-556"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bcp.2017.09.013","article-title":"Identification and validation of the microRNA response elements in the 3\u2032-untranslated region of the UDP glucuronosyltransferase (UGT) 2B7 and 2B15 genes by a functional genomics approach","volume":"146","author":"Papageorgiou","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"a004713","DOI":"10.1101\/mcs.a004713","article-title":"Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant","volume":"6","author":"Majounie","year":"2020","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.2217\/pgs.11.72","article-title":"Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity","volume":"12","author":"Amstutz","year":"2011","journal-title":"Pharmacogenomics"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/cpt.911","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update","volume":"103","author":"Amstutz","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2015.11.008","article-title":"Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time","volume":"54","author":"Lunenburg","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Etienne-Grimaldi, M.C., Boyer, J.C., Beroud, C., Mbatchi, L., van Kuilenburg, A., Bobin-Dubigeon, C., Thomas, F., Chatelut, E., Merlin, J.L., and Pinguet, F. (2017). New advances in DPYD genotype and risk of severe toxicity under capecitabine. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175998"},{"key":"ref_53","first-page":"A196","article-title":"Dpyd snps and disease free survival after capecitabine based adjuvant treatment in colorectal cancer","volume":"24","author":"Pellicer","year":"2017","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2017.03.007","article-title":"Potential role of CYP1B1 in the development and treatment of metabolic diseases","volume":"178","author":"Li","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Kwon, Y.J., Baek, H.S., Ye, D.J., Shin, S., Kim, D., and Chun, Y.J. (2016). CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt\/\u03b2-Catenin Signaling via Sp1 Upregulation. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0151598"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.3889\/oamjms.2019.667","article-title":"Polymorphisms in Phase I (CYP450) Genes CYP1A1 (rs4646421), CYP1B1 (rs1056836), CYP19A1 (rs749292)and CYP2C8 (rs1058930) and Their Relation to Risk of Breast Cancer: A Case-Control Study in Mazandaran Province in North of Iran","volume":"7","author":"Golmohammadzadeh","year":"2019","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.7150\/jca.21774","article-title":"A single nucleotide polymorphism in CYP1B1 leads to differential prostate cancer risk and telomere length","volume":"9","author":"Gu","year":"2018","journal-title":"J. Cancer"},{"key":"ref_58","first-page":"2286","article-title":"Tag SNPs detect association of the CYP1B1 gene with primary open angle glaucoma","volume":"16","author":"Burdon","year":"2010","journal-title":"Mol. Vis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"24362","DOI":"10.18632\/oncotarget.13848","article-title":"Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/pros.10348","article-title":"Metabolic susceptibility genes and prostate cancer risk in a southern European population: The role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms","volume":"58","author":"Medeiros","year":"2004","journal-title":"Prostate"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"6465","DOI":"10.4238\/2015.June.11.22","article-title":"Polymorphisms in GSTM1, GSTT1, GSTP1, and GSTM3 genes and breast cancer risk in northeastern Mexico","volume":"14","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1111\/jcmm.13528","article-title":"A novel functional polymorphism of GSTM3 reduces clear cell renal cell carcinoma risk through enhancing its expression by interfering miR-556 binding","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell. Mol. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1111\/jcmm.14315","article-title":"Multi-omics integrative analysis identified SNP-methylation-mRNA: Interaction in peripheral blood mononuclear cells","volume":"23","author":"Lu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/17425255.4.7.895","article-title":"The pregnane X receptor: From bench to bedside","volume":"4","author":"Ma","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.bbrc.2010.02.058","article-title":"Regulation of CYP3A4 by pregnane X receptor: The role of nuclear receptors competing for response element binding","volume":"393","author":"Istrate","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/00498250903420243","article-title":"Identification of polymorphisms in the 3\u2032-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism","volume":"40","author":"Oleson","year":"2010","journal-title":"Xenobiotica"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.apsb.2016.07.002","article-title":"PXR variants: The impact on drug metabolism and therapeutic responses","volume":"6","author":"Brewer","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_68","first-page":"3971","article-title":"Screening for the 3\u2032UTR Polymorphism of the PXR Gene in South Indian Breast Cancer Patients and its Potential Role in Pharmacogenomics","volume":"17","author":"Revathidevi","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2217\/14622416.9.11.1695","article-title":"PXR: A xenobiotic receptor of diverse function implicated in pharmacogenetics","volume":"9","author":"Zhang","year":"2008","journal-title":"Pharmacogenomics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbadis.2011.01.014","article-title":"Nuclear receptor PXR, transcriptional circuits andmetabolic relevance","volume":"181","author":"Ihunnah","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00228-020-02831-1","article-title":"Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: Influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms","volume":"76","author":"Zeng","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/jcpt.13084","article-title":"Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population","volume":"45","author":"Ren","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00228-013-1596-3","article-title":"Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXR\u03b1 and HNF4\u03b1) on docetaxel disposition in Chinese nasopharyngeal cancer patients","volume":"70","author":"Chew","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.dmpk.2016.01.003","article-title":"Human cytosolic sulfotransferase SULT1C4 mediates the sulfation of doxorubicin and epirubicin","volume":"2","author":"Luo","year":"2016","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/bj3460857","article-title":"Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain","volume":"346","author":"Falany","year":"2000","journal-title":"Biochem. J."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Ziats, C.A., Grosvenor, L.P., Sarasua, S.M., Thurm, A.E., Swedo, S.E., Mahfouz, A., Rennert, O.M., and Ziats, M.N. (2019). Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213921"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clnu.2011.08.005","article-title":"Combined effects of antioxidant vitamin and NOS3 genetic polymorphisms on breast cancer risk in women","volume":"31","author":"Lee","year":"2012","journal-title":"Clin. Nutr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s12094-015-1298-7","article-title":"Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies","volume":"17","author":"Ding","year":"2015","journal-title":"Clin. Transl. Oncol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e15932015","DOI":"10.1097\/MD.0000000000001593","article-title":"Predictive value of Ercc1 and Xpd polymorphisms for clinical outcomes of patients receiving neoadjuvant therapy: A PRISMA-compliant meta-analysis","volume":"94","author":"Qixing","year":"2015","journal-title":"Medicine"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/ijc.28200","article-title":"Strong expression of survivin is associated with positive response to radiotherapy and improved overall survival in head and neck squamous cell carcinoma patients","volume":"133","author":"Farnebo","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"8997","DOI":"10.4238\/2014.October.31.14","article-title":"Effect of ERCC1 polymorphism on theresponse to chemotherapy and clinical outcome of non-small cell lung cancer","volume":"31","author":"Gao","year":"2014","journal-title":"Genet. Mol. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"15017263","DOI":"10.4238\/gmr.15037864","article-title":"Association between ERCC1 and ERCC2 polymorphisms and breast cancer risk in a Chinese population","volume":"15","author":"Zhao","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"ref_84","first-page":"15065","article-title":"Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy","volume":"8","author":"Mo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2008.19.1718","article-title":"Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: A study of the arbeitsgemeinschaft internistische onkologie","volume":"27","author":"Goekkurt","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2017.01.016","article-title":"Biological and predictive role of ERCC1 polymorphisms in cancer","volume":"111","author":"Formica","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_87","first-page":"e150902019","article-title":"The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"48130","DOI":"10.18632\/oncotarget.10173","article-title":"Polymorphisms of multiple genes involved in NER pathway predict prognosis of gastric cancer","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/jid.2012.498","article-title":"Polymorphisms of nucleotide excision repair genes predict melanoma survival","volume":"133","author":"Li","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Szab\u00f3, E., T\u00fcrk, D., Telbisz, \u00c1., Kucsma, N., Horv\u00e1th, T., Szak\u00e1cs, G., Homolya, L., Sarkadi, B., and V\u00e1rady, G. (2018). A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0190629"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zhao, T.Y., Lei, S., Huang, L., Wang, Y.N., Wang, X.N., Zhou, P.P., Xu, X.J., Zhang, L., Xu, L.W., and Yang, L. (2019). Associations of Genetic Variations in ABCA1 and Lifestyle Factors with Coronary Artery Disease in a Southern Chinese Population with Dyslipidemia: A Nested Case-Control Study. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16050786"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10637-009-9347-0","article-title":"Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors","volume":"29","author":"Steeghs","year":"2011","journal-title":"Investig. New Drugs"},{"key":"ref_93","unstructured":"(2021, September 13). SNPinfo Web Server, Available online: https:\/\/snp.info.niehs.nih.gov."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12967-017-1339-9","article-title":"Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients","volume":"15","author":"Cao","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"El-Murr, N., Abidi, Z., Wanherdrick, K., Svrcek, M., Gaub, M.P., Fl\u00e9jou, J.F., Hamelin, R., Duval, A., and Lesuffleur, T. (2012). MiRNA genes constitute new targets for microsatellite instability in colorectal cancer. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031862"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jcph.165","article-title":"ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients","volume":"53","author":"Coelho","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/carcin\/bgy062","article-title":"Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival","volume":"39","author":"Freedman","year":"2018","journal-title":"Carcinogenesis"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1096\/fj.201800956R","article-title":"ABCB1 (P-glycoprotein) regulates vitamin D absorption and contributes to its transintestinal efflux","volume":"33","author":"Margier","year":"2019","journal-title":"FASEB J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ajh.2009.3","article-title":"Steroid biosynthesis and renal excretion in human essential hypertension: Association with blood pressure and endogenous ouabain","volume":"22","author":"Tripodi","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/mp.2009.92","article-title":"Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: Association with major depression and antidepressant response in Mexican-Americans","volume":"14","author":"Dong","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"ref_101","first-page":"185","article-title":"Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome","volume":"2","author":"Peethambaram","year":"2011","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1681\/ASN.2012030260","article-title":"Donor ABCB1 variant associates with increased risk for kidney allograft failure","volume":"23","author":"Moore","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Johnson, D.H., Sutherland, D., Acosta, E.P., Erdem, H., Richardson, D., and Haas, D.W. (2013). Genetic and non-genetic determinants of raltegravir penetration into cerebrospinal fluid: A single arm pharmacokinetic study. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082672"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"689","DOI":"10.3851\/IMP3063","article-title":"ABCC4, ABCC5 and SLC28A1 polymorphisms: Host genome on responses of chronic hepatitis B patients with entecavir treatment","volume":"21","author":"Yuan","year":"2016","journal-title":"Antivir. Ther."},{"key":"ref_105","unstructured":"(2021, September 13). GeneCards: The Human Gene Database. Available online: https:\/\/www.genecards.org."},{"key":"ref_106","first-page":"717","article-title":"Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer","volume":"30","author":"Singhal","year":"2007","journal-title":"Int. J. Oncol."},{"key":"ref_107","first-page":"e4672","article-title":"Frequency of Chemotherapy Induced Anemia in Breast Cancer Patients","volume":"10","author":"Pourali","year":"2017","journal-title":"Iran J. Cancer Prev."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0009-9236(95)90158-2","article-title":"A population model for the leukopenic effect of etoposide","volume":"57","author":"Karlsson","year":"1995","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","article-title":"Drug-Induced Myelosuppression","volume":"26","author":"Carey","year":"2003","journal-title":"Drug-Safety"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","article-title":"Chemotherapy-induced anemia in adults: Incidence and treatment","volume":"91","author":"Groopman","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_111","first-page":"2753","article-title":"Association and correlation of different chemotherapeutic regimens and doses with onset and severity of anemia among solid cancer patients","volume":"12","author":"Hassan","year":"2011","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/jjco\/hyaa047","article-title":"Four versus six chemotherapy cycles in endometrial carcinoma with a high risk of recurrence: A retrospective study","volume":"50","author":"Mayama","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_113","first-page":"S259","article-title":"Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies","volume":"23","author":"Adel","year":"2017","journal-title":"Am. J. Manag. Care"},{"key":"ref_114","first-page":"6","article-title":"The quest for reliable prediction of chemotherapy induced delayed nausea among breast cancer patients","volume":"4","author":"McCourt","year":"2019","journal-title":"J. Unexplored Med. Data"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00520-010-0982-y","article-title":"Risk factors at pretreatment predicting treatment-induced nausea and vomiting in Australian cancer patients: A prospective, longitudinal, observational study","volume":"19","author":"Pirri","year":"2011","journal-title":"Support Care Cancer"},{"key":"ref_116","first-page":"W1","article-title":"Identifying patients at high risk for nausea and vomiting after chemotherapy: The development of a practical prediction tool I. Acute Nausea and Vomiting","volume":"7","author":"Dranitsaris","year":"2009","journal-title":"J. Supp. Oncol."},{"key":"ref_117","first-page":"W9","article-title":"Identifying patients at high risk for nausea and vomiting after chemotherapy: The development of a practical validated prediction tool II. Delayed Nausea and Vomiting","volume":"7","author":"Petrella","year":"2009","journal-title":"J. Supp. Oncol."},{"key":"ref_118","first-page":"877","article-title":"Control of Nausea and Vomiting in Patients Receiving Anthracycline\/Cyclophosphamide Chemotherapy for Breast Cancer","volume":"38","author":"Kobayashi","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00520-010-1073-9","article-title":"Chemotherapy-induced nausea and vomiting in daily clinical practice: A community hospital-based study","volume":"20","author":"Hilarius","year":"2012","journal-title":"Support Care Cancer"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10549-017-4155-2","article-title":"Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients","volume":"63","author":"Goorts","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/path.4288","article-title":"Metastatic progression of breast cancer: Insights from 50 years of autopsies","volume":"232","author":"Cummings","year":"2014","journal-title":"J. Pathol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years","volume":"377","author":"Pan","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_123","first-page":"4252","article-title":"Genomic landscape of metastatic breast cancer identifies preferentially dysregulated pathways and targets","volume":"130","author":"Paul","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s12032-013-0615-7","article-title":"Outcomes of locally advanced breast cancer patients with \u2265 10 positive axillary lymph nodes","volume":"30","author":"Koca","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10549-017-4480-5","article-title":"Outcome after neoadjuvant chemotherapy in estrogen receptor-positive and progesterone receptor-negative breast cancer patients: A pooled analysis of individual patient data from ten prospectively randomized controlled neoadjuvant trials","volume":"167","author":"Denkert","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tem.2015.08.002","article-title":"Progesterone receptor-estrogen receptor crosstalk: A novel insight","volume":"26","author":"Thomas","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature14583","article-title":"Progesterone receptor modulates ER\u03b1 action in breast cancer","volume":"523","author":"Mohammed","year":"2015","journal-title":"Nature"},{"key":"ref_128","first-page":"283","article-title":"Estrogen receptor, progesterone receptor, and Her 2 Neu positivity and its association with tumour characteristics and menopausal status in a breast cancer cohort from northern Pakistan","volume":"6","author":"Faheem","year":"2012","journal-title":"Ecancermedicalscience"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00280-019-03981-5","article-title":"Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy","volume":"85","author":"Rossi","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_130","unstructured":"(2021, September 13). ECOG Common Toxicity Criteria. Available online: https:\/\/www3.med.unipmn.it\/master\/DM\/2010\/Settembre_2010\/Statistica%20Magnani\/ctc_ecog.pdf."},{"key":"ref_131","unstructured":"(2021, December 13). Bio-Mart Ensembl Database. Available online: https:\/\/www.ensembl.org\/index.html."},{"key":"ref_132","unstructured":"(2021, September 13). PubMed Database, Available online: https:\/\/www.ncbi.nlm.nih.gov\/pubmed."},{"key":"ref_133","unstructured":"(2021, September 13). dbSNP Database, Available online: https:\/\/www.ncbi.nlm.nih.gov\/snp\/."},{"key":"ref_134","unstructured":"(2021, September 13). Primer3Plus. Available online: http:\/\/primer3plus.com\/cgi-bin\/dev\/primer3plus.cgi."},{"key":"ref_135","unstructured":"(2021, September 13). Primer-BLAST, Available online: https:\/\/www.ncbi.nlm.nih.gov\/tools\/primer-blast\/."},{"key":"ref_136","unstructured":"(2021, September 13). WatCut. Available online: http:\/\/watcut.uwaterloo.ca\/template.php."},{"key":"ref_137","unstructured":"(2021, September 13). NEBcutter v 2.0. Available online: http:\/\/www.labtools.us\/nebcutter-v2-0\/."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/DMDI.2011.027","article-title":"Variation and evolution of the ABC transporter genes ABCB1, ABCC1, ABCG2, ABCG5 and ABCG8: Implication for pharmacogenetics and disease","volume":"26","author":"Silverton","year":"2011","journal-title":"Drug Metabol. Drug Interact."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"277","DOI":"10.5603\/njo.95605","article-title":"The importance of selected biomarkers in the clinical practice of breast cancer patients","volume":"73","author":"Kotowicz","year":"2023","journal-title":"Nowotwory J. Oncol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.31557\/APJCP.2020.21.7.1925","article-title":"ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy","volume":"21","author":"Liblab","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00228-011-1007-6","article-title":"Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer","volume":"67","author":"Bergmann","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"66790","DOI":"10.18632\/oncotarget.11053","article-title":"Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients","volume":"7","author":"Tecza","year":"2016","journal-title":"Oncotarget"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.18632\/oncotarget.24148","article-title":"Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients","volume":"9","author":"Tecza","year":"2018","journal-title":"Oncotarget"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12283\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:33:12Z","timestamp":1760113992000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/22\/12283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":143,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["ijms252212283"],"URL":"https:\/\/doi.org\/10.3390\/ijms252212283","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}